Globeflex Capital’s Filana Therapeutics FLNA Stock Holding History

Globeflex Capital’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-49	Closed	-$1K	–	676
2013 Q4	$1K	Buy	+49	New	+$1.3K	﹤0.01%	534

Other funds holding FLNA

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

MSP

Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Globeflex Capital's FLNA Position: Q1 2014 in Review

Globeflex Capital sold out of Filana Therapeutics (FLNA) in Q1 2014, closing a stake of 49 shares — an estimated $1K sold.

Globeflex Capital first reported a position in FLNA in Q4 2013 and held it in 1 quarter. The position peaked at $1K in Q4 2013. 75 funds tracked by Wall St. Rank hold FLNA as of Q1 2014.

Globeflex Capital reported no remaining Filana Therapeutics position as of Q1 2014 after selling out during the quarter.
Globeflex Capital sold 49 Filana Therapeutics shares in Q1 2014, an estimated $1K.
Globeflex Capital first reported a position in Filana Therapeutics in Q4 2013 and held it in 1 quarter.
Globeflex Capital's Filana Therapeutics position peaked at $1K in Q4 2013.
75 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2014.

Based on Globeflex Capital's 13F filing for Q1 2014, filed 23 Apr 2014.